from Taxus-Stent.com: The TAXUS™ Express²™ Paclitaxel-Eluting
Coronary Stent System has the power to reduce restenosis, treat a variety
of lesions and achieve safe, predictable outcomes for patients.
Efficacy - The TAXUS Express² Stent
has demonstrated consistently low revascularization rates throughout
the stent, including its edges and across a broad range of
patient and lesion types.
Safety - The TAXUS Stent has demonstrated
consistent safety results and endothelial healing across trials
and lesions.
Performance - The proven Express² Stent
platform exhibits excellent deliverability and conformability,
allowing you to treat a variety of lesions and making it easy
to achieve complete stent apposition.
For more detailed information on the Taxus stent,
read our profile of the device.
send comments & suggestions
to "info at angioplasty dot org"
Read our Privacy statement.
Angioplasty.Org is an editorially independent informational health
site
which has received unrestricted educational grants from Medtronic plc,
TCROSS NEWS, Toshiba
America
Medical Systems, Volcano
Corporation, Terumo
Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY
